Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 26 for:    maitre

Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03232931
Recruitment Status : Recruiting
First Posted : July 28, 2017
Last Update Posted : September 10, 2020
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Nathalie Maitre, Nationwide Children's Hospital

Brief Summary:
Every year, almost all of ½ million infants born prematurely in the US and 15 million worldwide suffer from abnormal brain maturation resulting from interactions between immaturity and atypical sensory experiences after birth. The current proposal uses rigorous scientific methods to measure the effects and determine the mechanisms of action of a parent-supported multisensory neurorehabilitative intervention for preterm infants, adaptable to a wide variety of neonatal environments, even when parents cannot be at their child's bedside. The intervention aims to improve brain multisensory processing, reactions to sensory stimulation in the home and long term language and motor development.

Condition or disease Intervention/treatment Phase
Preterm Infant Device: Multisensory intervention Behavioral: Standard of care Not Applicable

Detailed Description:
The proposed is a randomized controlled trial design with intent-to-treat analysis in hospitalized preterm infants between 32 and 36 weeks post-menstrual age. Both the control and intervention groups will receive routine neonatal intensive care unit care (i.e., skin-to-skin care by parent when available and daily sessions of exposure to recorded parent's voice). In addition to routine care, the parent-supported multisensory intervention consists of 10 sessions of standardized, therapist-administered, auditory-tactile stimulation that combines contingent recorded mother's voice delivered using a pacifier-activated system, during holding with supportive tactile containment against the therapist's chest, covered by cloth imprinted with mother's scent. Possible covariates, multi- and uni- sensory processing, will be measured at entry into the study and immediately after the treatment phase. Sensory reactivity will be measured at 1 year of age and language and motor outcomes will be assessed at 2 years. Except for parent reports, all measures will be administered by masked examiners.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A randomized controlled trial design with intent-to-treat analysis in hospitalized preterm infants between 32 and 36 weeks post-menstrual age. Both the control and intervention groups will receive routine neonatal intensive care protocols (including skin-to-skin care by parent when available and daily sessions of exposure to recorded parent's voice). In addition to routine care, the parent-supported multisensory intervention consists of 10 sessions of standardized, therapist-administered, auditory-tactile stimulation that combines contingent recorded mother's voice delivered using a pacifier-activated system, during holding with supportive tactile containment against the therapist's chest, covered by cloth imprinted with mother's scent. Possible covariates, multi- and uni- sensory processing, will be measured at entry into the study and immediately after the treatment phase. Sensory reactivity will be measured at 1 year and language and motor outcomes will be assessed at 2 years.
Masking: Single (Outcomes Assessor)
Masking Description: Except for parent reports, all measures will be administered by masked examiners.
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants
Actual Study Start Date : October 29, 2018
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : May 30, 2023

Arm Intervention/treatment
Experimental: Intervention
The Multisensory intervention will be carried out in addition to standard care and will include 2 components: (1) holding and light pressure containment of the infant against the hospital-gown covered chest of the therapist for tactile and non-specific auditory stimulation simultaneous with (2) playing of mother's voice contingent on infant pacifier sucking for the first 20 minutes of holding. Additionally, a gauze square scented with parent's skin will be used to provide olfactory stimulation.
Device: Multisensory intervention
The intervention will be carried out in addition to standard care and will include 2 components: (1) holding and light pressure containment of the infant against the hospital-gown covered chest of the therapist for tactile and non-specific auditory stimulation simultaneous with (2) playing of mother's voice contingent on infant pacifier sucking for the first 20 minutes of holding. Additionally, a gauze square scented with parent's skin will be used to provide olfactory stimulation.

Control (standard of care)
The standard care of infant currently follows 2 medical protocols, one for parental Skin-to-Skin holding and one for exposure to parent's voice.
Behavioral: Standard of care
Standard of care: parental skin-to-skin care and exposure to parent's voice




Primary Outcome Measures :
  1. Latency of response to auditory and tactile stimuli on EEG/ERP [ Time Frame: at enrollment up to 36 weeks gestation and at intervention completion up to 42 weeks gestation ]
    Change from baseline event related potential multisensory response at term-equivalent age (up to 42 weeks gestation)


Secondary Outcome Measures :
  1. Infant/Toddler Sensory Profile (ITSP) [ Time Frame: at 12 months corrected age ]

    Infant/Toddler Sensory Profile: A caregiver questionnaire used to measure sensory reactivity and adaptation to the environment of children birth to 36 months. The Infant/Toddler Sensory Profile consists of 48 items for children 7 to 36 months. The caregiver questionnaire contains items divided into sensory systems. For children 7 to 36 months, there are five sensory processing section scores, four quadrant scores, and one combined quadrant score available. For children 12 months corrected age, the four quadrant score ranges are as follows:

    Low Registration: 11-55 ("typical" is 46-54) Sensation Seeking: 14-70 ("typical" is 19-35) Sensory Sensitivity: 11-55 ("typical" is 41-52) Sensation Avoiding: 12-60 ("typical" is 45-56)


  2. Motor and language scores on Bayley-III [ Time Frame: 12 and 24 months corrected age ]
    Bayley Scales of Infant and Toddler Development (Bayley-III): Standardized comprehensive assessment tool for assessing child development in children one month to 42 months old. The highest possible scaled score on each subtest is 19, and the lowest possible score is 1. Scores from 8 to 12 are considered average. Composite scores for motor and language domains are derived from sums of the subtest scaled scores. Composite scores range from 40-160.

  3. Preschool Language Scales, Fifth Edition (PLS-5) [ Time Frame: 24 months corrected age ]
    Preschool Language Scales, Fifth Edition (PLS-5): An interactive assessment of developmental language skills in children birth-7. A standard score of 100 reflects the average performance of children in a given age range.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   32 Weeks to 35 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Hospitalization at Nationwide Children's Hospital
  • Postmenstrual Age 32 0/7-35 6/7

Exclusion Criteria:

  • Ventilation using an endotracheal tube
  • Major congenital malformations
  • Family history of genetic hearing loss
  • Use of sedatives or seizure medications

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03232931


Contacts
Layout table for location contacts
Contact: Stephanie Burkhardt, MPH (614) 722-4883 Stephanie.burkhardt@nationwidechildrens.org

Locations
Layout table for location information
United States, Ohio
Stephanie Burkhart Recruiting
Columbus, Ohio, United States, 43205
Contact: Stephanie Burkhart, MPH    301-712-8852    stephanie.burkhardt@nationwidechildrens.org   
Contact: Stephanie Burkhart    13017128852      
Sponsors and Collaborators
Nationwide Children's Hospital
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Layout table for investigator information
Principal Investigator: Nathalie L Maitre, MD, PhD Nationwide Children's Hospital
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Nathalie Maitre, Associate Professor and Principal Investigator, Nationwide Children's Hospital
ClinicalTrials.gov Identifier: NCT03232931    
Other Study ID Numbers: IRB17-00025
R01HD093706 ( U.S. NIH Grant/Contract )
First Posted: July 28, 2017    Key Record Dates
Last Update Posted: September 10, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Nathalie Maitre, Nationwide Children's Hospital:
auditory
tactile
mother's voice
multisensory
Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications